Fiche centre
Jeonbuk National University Hospital
Jeonju — South Korea
Essais liés3clinical trials
VilleJeonjulocalisation
PaysSouth Korealocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05660967
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| In-hospital staged complete revascularization | Maladie coronarienne | Non applicable | NCT07741721 | Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2) | RECRUITING |
| Zastaprazan | Accident vasculaire cérébral | Phase 3 | NCT07730840 | Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke | NOT_YET_RECRUITING |
| Epcoritamab | SEP | Phase 2 | NCT05660967 | EPCORE DLBCL-3 — Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma | TERMINATED |